References
- ADAMS, S. S., CLIFFE, E. E., LESSEL, B. and NICHOLSON, J. S., 1967, Some biological properties of 2-(4-isobutylphenyl)propionic acid. Journal of Pharmaceutical Sciences, 56, 1686.
- AVGERINOS, A. and HUTT, A. J., 1990, Interindividual variability in the enantiomeric disposition of ibuprofen following the oral administration of the racemic drug to healthy volunteers. Chira/ity, 2, 249–256.
- BAILLIE, T. A., ADAMS, W. J., KAISER, D. G., OLANoFF, L. S., HALSTEAD, G. W., HARPOOTLIAN, H. and VAN GIESSEN, G. J., 1989, Mechanistic studies of the metabolic chiral inversion of (R)-ibuprofen in humans. Journal of Pharmacology and Experimental Therapeutics, 249, 517–523.
- BJDRNSDOTTIR, I., KEPP, D. R. TJORNELUND, J. and HANSEN, S. H., 1998, Separation of the enantiomers of ibuprofen and its major phase I metabolites in urine using capillary-electrophoresis. Electrophoresis, 19, 455–460.
- BROOKS, C. J. W. and GILBERT, M. T., 1974, Studies of urinary metabolites of 2-(4-isobutylphenyl)propionic acid by gas-liquid chromatography-mass spectrometry. Journal of Chromatography, 99, 541–551.
- CALDWELL, J., HUTT, A. J. and FOURNEL-GIGLEUX, S., 1988, The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences. Biochemical Pharmacology, 37, 105–114.
- CHEN, C.-Y. and CHEN, C.-S., 1994, Stereoselective disposition of ibuprofen in patients with renal dysfunction. Journal of Pharmacology and Experimental Therapeutics, 268, 590–594.
- DAVIES, N. M., 1998, Clinical pharmacokinetics of ibuprofen. The first 30 years. Clinical Pharmacokinetics, 34, 101–154.
- EL-MouEuii, M., RUELIUS, H. W., FENSELAU, C. and DULIK, D. M., 1987, Species-dependent enantioselective glucuronidation of three 2-arylpropionic acids. Naproxen, ibuprofen and benoxaprofen. Drug Metabolism and Disposition, 15, 767–772.
- EVANS, A. M., NATION, R. L. and SANSOM, L. N., 1989a, Lack of effect of cirnetidine on the pharmacokinetics of R(-)- and S(+)-ibuprofen. British Journal of Clinical Pharmacology, 28, 143–149.
- EVANS, A. M., NATION, R. L., SANSOM, L. N. BOCHNER, F. and SOMOGYI, A. A., 1989b, Stereoselective plasma protein binding of ibuprofen enantiomers. European Journal of Clinical Pharmacology, 36, 283–290.
- EVANS, A. M., NATION, R. L., SANSOM, L. N. BOCHNER, F. and SOMOGYI, A. A., 1990, The relationship between the pharmacokinetics of ibuprofen enantiomers and the dose of racemic ibuprofen in humans. Biopharmaceutics and Drug Disposition, 11, 507–518.
- FANALI, S., DESIDERIO, C., SCHULTE, G., HEITMEIER, S., STRICKMANN, D., CHANKVETADZE, B. and BLASCHKE, G., 1998, Chiral capillary electrophoresis-electrospray mass spectrometry coupling using vancomycin as chiral selector. Journal of Chromatography A, 800, 69–76.
- FRENEAUX, E., FROMENTY, B., BERSON, A., LABBE, G., DEGOTT, C., LETTERON, P., LARREY, D. and PESSAYNE, D., 1990, Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial O.oxidation of fatty acids. Journal of Pharmacology and Experimental Therapeutics, 255, 529–535.
- GEISSLINGER, G., SCHUSTER, O., STOCK, K. P., LOEW, D., BACH, G. L. and BRUNE, K., 1990, Pharmacokinetics of S(+ )- and R(-)-ibuprofen in volunteers and first clinical experience of S(+ )-ibuprofen in rheumatoid arthritis. European Journal of Clinical Pharmacology, 38, 493–497.
- GEISSLINGER, G., STOCK, K. P., LOEW, D., BAcu, G. L. and BRUNE, K., 1993, Variability in the stereoselective disposition of ibuprofen in patients with rheumatoid arthritis. British Journal of Clinical Pharmacology, 35, 603–607.
- HALL, S. D., RUDY, A. C. KNIGHT, P. M. and BRATER, D. C., 1993, Lack of presystemic inversion of (R)- to (S)-ibuprofen in humans. Clinical Pharmacology and Therapeutics, 53, 393–400.
- HAYBALL, P. J., 1996, Chirality and nonsteroidal anti-inflammatory drugs. Drugs, 52 (Suppl 5), 47–58.
- HEINZEL, G., WOLOSZCZAK, P. and THOMANN, P. (eds), 1993, Non-compartment analysis-methods manual. In TOPFIT 2.0-Pharmacodynamk Data Analysis System (Stuttgart: Fischer), pp 5–64.
- HUANG, J. D., 1983, Errors in estimating the unbound fraction of drugs due to the volume shift in equilibrium dialysis. Journal of Pharmaceutical Sciences, 72, 1368–1369.
- HUTT, A. J. and CALDWELL, J., 1983, The metabolic chiral inversion of 2-arylpropionic acids — a novel route with pharmacological consequences. Journal of Pharmacy and Pharmacology, 35, 693–704.
- KAISER, D. G., VAN GIESSEN, G. J., REISCHER, R. J. and WECHTER, W. J., 1976, Isomeric inversion of ibuprofen (R)-enantiomer in humans. Journal of Pharmaceutical Sciences, 65, 269–273.
- KEPP, D. R., SIDELMANN, U. G. and HANSEN, S. H., 1997, Isolation and characterization of major phase I and II metabolites of ibuprofen. Pharmaceutical Research, 14, 676–680.
- KNIGHTS, K. M., MCLEAN, C. F., TONKIN, A. L. and MINERS, J. O., 1995, Lack of effect of gender and oral contraceptive steroids on the pharmacokinetics of (R)-ibuprofen in humans. British Journal of Clinical Pharmacology, 40, 153–156.
- KNIGHTS, K. M., TALBOT, U. M. and BAILLIE, T. A., 1992, Evidence of multiple forms of rat liver microsomal coenzyme A ligase catalysing the formation of 2-arylpropionyl-coenzyme A thioesters. Biochemical Pharmacology, 44, 2415–2417.
- KNIHINICKI, R. D., DAY, R. O. and WILLIAMS, K. M., 1989, Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs I. In vitro studies of ibuprofen and flurbiprofen. Biochemical Pharmacology, 38, 4389–4395.
- KNIHINICKI, R. D., DAY, R. O. and WILLIAMS, K. M., 1991, Chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs II. Racemization and hydrolysis of (R)- and (S)-ibupr ofen-Co A thioesters. Biochemical Pharmacology, 42, 1905–1911.
- LEE, E. J. D., WILLIAMS, K., DAY, R., GRAHAM, G. and CHAMPION, D., 1985, Stereoselective disposition of ibuprofen enantiomers in man. British Journal of Clinical Pharmacology, 19, 669–674.
- Li, G., TREIBER, G., MAIER, K., WALKER, S. and KLOTZ, U., 1993, Disposition of ibuprofen in patients with liver cirrhosis. Stereochemical considerations. Clinical Pharmacokinetics, 25, 154–163.
- LOCKWOOD, G. F., ALBERT, K. S., GILLESPIE, W. R., BOLE, G. G., HARKCOM, T. M., SZPUNAR, G. J. and WAGNER, J. G., 1983, Pharmacokinetics of ibuprofen in man I. Free and total area/dose relationships. Clinical Pharmacology and Therapeutics, 34, 97–103.
- MAYER, J. M., 1990, Stereoselective metabolism of anti-inflammatory 2-arylpropionates. Ada Pharmaceutica Nordica, 2, 197–215.
- MENZEL, S., WAIBEL, R., BRUNE, K. and GEISSLINGER, G., 1994, Is the formation of R-ibuprofenyl-adenylate the first stereoselective step of chiral inversion? Biochemical Pharmacology, 48, 1056–1058.
- MILLS, R. F. N., ADAMS, S. S., CLIFFE, E. E., DICKINSON, W. and NICHOLSON, J. S., 1973, The metabolism of ibuprofen. Xenobiotica, 3, 589–598.
- PALiwAL, J. K., SMITH, D. E., Cox, S. R., BERARDI, R. R., DUNN-KUCHARSKI, V. A. and ELTA, G. H., 1993, Stereoselective, competitive and nonlinear plasma protein binding of ibuprofen enantiomers as determined in vivo in healthy subjects. Journal of Pharmacokinetics and Biopharmaceutics, 21, 145–161.
- PETTERSON, J. E., ULSAKER, G. A. and JELLUM, E., 1978, Studies on the metabolism of 2,4'-isobutylphenylpropionic acid (ibuprofen) by gas-chromatography and mass spectrometry. Dialysis fluid, a convenient medium for studies on drug metabolism. Journal of Chromatography. Biomedical Applications, 145, 413–420.
- ROWLAND, M. and TOZER, T. N., 1995, Metabolite kinetics. In M. Rowland and T. N. Tozer (eds), Clinical Pharmacokinetics, (Philadelphia: Lea & Febiger) pp. 367–394.
- ROY-DE Vos, M., MAYER, J. M., ETTER, J.C. and TESTA, B., 1996, Clofibric acid increases the unidirectional chiral inversion of ibuprofen in rat liver preparations. Xenobiotica, 26, 571–582.
- RUDY, A. C., ANLIKER, K. S. and HALL, S. D., 1990, High-performance liquid chromatographic determination of the stereoisomeric metabolites of ibuprofen. Journal of Chromatography. Biomedical Applications, 528, 395–405.
- RUDY, A. C., BRADLEY, J. D., RYAN, S. I., KALASINSKI, L. A., XIAOTAO, Q. and HALL, S. D., 1992, Variability in the disposition of ibuprofen enantiomers in osteoarthritis patients. Therapeutic Drug Monitoring, 14, 464–470.
- RUDY, A. C., KNIGHT, P. M., BRATER, D. C. and HALL, S. D., 1991, Stereoselective metabolism of ibuprofen in humans: administration of R- and S- and racemic ibuprofen. Journal of Pharmacology and Experimental Therapeutics, 259, 1133–1139.
- RUDY, A. C., KNIGHT, P. M., BRATER, D. C. and HALL, S. D., 1995, Enantioselective disposition of ibuprofen in elderly persons with and without renal impairment. Journal of Pharmacology and Experimental Therapeutics, 273, 88–93.
- SANINS, S. M., ADAMS, W. J., KAISER, D. G., HALSTEAD, G. W., HOSLEY, J., BARNES, H. and BAILLIE, T. A., 1991, Mechanistic studies on the metabolic chiral inversion of R-ibuprofen in the rat. Drug Metabolism and Disposition, 19, 405–410.
- SCHEUERER, S., HALL, S. D., WILLIAMS, K. M. and GEISSLINGER, G., 1998, Effect of clofibrate on the chiral inversion of ibuprofen in healthy volunteers. Clinical Pharmacology and Therapeutics, 64, 168–176.
- SHIEH, W.-R. and CHEN, C.-S., 1993, Purification and characterization of novel `2-arylpropionyl-CoA epimerases' from rat liver cytosol and mitochondria. Journal of Biological Chemistry, 268, 3487–3493.
- SHIEH, W.-R., Gou, D.-M., Liu, Y.-C., CHEN, C.-S. and CHEN, C.-Y., 1993, A 13C-NNIR study on ibuprofen metabolism in isolated rat liver mitochondria. Analytical Biochemistry, 212, 143–149.
- SHIRLEY, M. A., GUAN, X., KAISER, D. G., HALSTEAD, G. W. and BAILLIE, T. A., 1994, Taurine conjugation of ibuprofen in humans and in rat liver in vitro. Relationship to metabolic chiral inversion. Journal of Pharmacology and Experimental Therapeutics, 269, 1166–1175.
- SMITH, D. E., PALiwAL, J. K., Cox, S. R., BERARDI, R. R., DUNN-KUCHARSKI, V. A. and ELTA, G. H., 1994, The effect of competitive and non-linear plasma protein binding on the stereoselective disposition and metabolic inversion of ibuprofen in healthy subjects. Biopharmaceutics and Drug Disposition, 15, 545–561.
- TAN, S. C., BAKER, J. A., STEVENS, N., DE BIASI, V., SALTER, C., CHALAUX, M., AFARINKIA, K. and HUTT, A. J., 1997a, Synthesis, chromatographic resolution and chiroptical properties of carboxyibuprofen stereoisomers: major metabolites of ibuprofen in man. Chira/ity, 9, 75–87.
- TAN, S. C., JACKSON, S. H. D., SWIFT, C. G. and HUTT A. J., 1997b, Stereospecific analysis of the major metabolites of ibuprofen in urine by sequential achiral-chiral high-performance liquid chromatography. Journal of Chromatography B, 701, 53–63.
- TAN, S. C., JACKSON, S. H. D., SWIFT, C. G. and HUTT A. J., 1997c, Enantiospecific analysis of ibuprofen by high-performance liquid chromatography: determination of free and total drug enantiomer concentrations in serum and urine. Chromatographia, 46, 23–32.
- TRACY, T. S., WIRTHWEIN, D. P. and HALL, S. D., 1993, Metabolic inversion of (R)-ibuprofen. Formation of ibuprofenyl- coenzymeA. Drug Metabolism and Disposition, 21, 114–120.
- WECHTER, W. J., LOUGHHEAD, D. G., REISCHER, R. J., VAN GIESSEN, G. J. and KAISER, D. G., 1974, Enzymatic inversion at saturated carbon: nature and mechanism of the inversion of R(-)-p-iso-butylhydratropic acid. Biochemical and Biophysical Research Communications, 61, 833–837.
- WILLIAMS, K. M., DAY, R. O., KNIHINICKI, R. D. and DurriELD, A., 1986, The stereoselective uptake of ibuprofen enantiomers into adipose tissue. Biochemical Pharmacology, 35, 3403–3405.
- ZNAO, B., GEISSLINGER, G., HALL, I., DAY, R. O. and WILLIAMS, K. M., 1992, The effect of the enantiomers of ibuprofen and flurbiprofen on the O.oxidation of palmitate in the rat. Chirafity, 4, 137–141.